Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Imaging in cervical cancer.

Michele Follen1, Charles F Levenback, Revathy B Iyer

  • 1Department of Gynecologic Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA. mfollen@mdanderson.org

Cancer
|November 7, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Initial clinical experience with [<sup>177</sup>Lu]Lu-PNT2002 radioligand therapy in metastatic castration-resistant prostate cancer: dosimetry, safety, and efficacy from the lead-in cohort of the SPLASH trial.

Frontiers in oncology·2025
Same author

Alpha-emitter therapy for pediatric relapsed metastatic pancreatic neuroendocrine tumor.

Pediatric blood & cancer·2024
Same author

Effectiveness and Safety of Retreatment with <sup>177</sup>Lu-DOTATATE in Patients with Progressive Neuroendocrine Tumors: A Retrospective Real-World Study in the United States.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2024
Same author

Toward Integrated Independence: Johannes Czernin Discusses the Future of Theranostics with Ebrahim Delpassand, Eric Rohren, and Wolfgang Weber.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2023
Same author

Diagnostic Value of Radiolabelled Somatostatin Analogues for Neuroendocrine Tumour Diagnosis: The Benefits and Drawbacks of [<sup>64</sup>Cu]Cu-DOTA-TOC.

Cancers·2022
Same author

Targeted <b>α</b>-Emitter Therapy with <sup>212</sup>Pb-DOTAMTATE for the Treatment of Metastatic SSTR-Expressing Neuroendocrine Tumors: First-in-Humans Dose-Escalation Clinical Trial.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2022
Same journal

Real-world effectiveness of chemotherapy regimens after immunotherapy in patients with advanced melanoma in Spain: Results from the GEM1801 study.

Cancer·2026
Same journal

Bendamustine in indolent lymphoma: Letting the dust settle down.

Cancer·2026
Same journal

Top advances of the year: Bispecific antibodies in early lines of therapy in multiple myeloma.

Cancer·2026
Same journal

Direct oral anticoagulants and warfarin in atrial fibrillation patients with cancer by anticoagulation quality.

Cancer·2026
Same journal

Sexual orientation and gender identity based disparities in colorectal, cervical, and breast cancer screening in the United States.

Cancer·2026
Same journal

Toward exercise as standard care for older cancer survivors.

Cancer·2026
See all related articles

Advances in medical imaging, including CT, MRI, and PET scans, enhance cervical cancer staging by detecting lymph node metastases and distant micrometastases, improving treatment and survival rates.

Area of Science:

  • Oncology
  • Radiology
  • Gynecology

Background:

  • Cervical cancer staging has traditionally relied on clinical methods.
  • Improved imaging techniques offer potential for more accurate detection of metastases.
  • Accurate staging is crucial for effective treatment selection and patient survival.

Purpose of the Study:

  • To review recent advances in imaging technologies for cervical cancer staging.
  • To assess the impact of these advances on diagnosis, treatment, and survival.
  • To evaluate the role of various imaging modalities in detecting lymph node and distant metastases.

Main Methods:

  • Review of advancements in lymphangiography, ultrasonography, computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET), and lymphatic mapping.

Related Experiment Videos

  • Analysis of the sensitivity and specificity of different imaging techniques.
  • Evaluation of the impact of new contrast agents and combined imaging approaches.

    • Main Results:

    • While lymphangiography has limited use, its sensitivity/specificity vary.
    • Ultrasonography's role may expand with new contrast agents for parametrial invasion and lymph node assessment.
    • MRI offers superior soft tissue contrast for determining tumor size, invasion, and nodal characteristics.
    • PET detects abnormal lymph node regions better than CT and can identify chemoradiation-unresponsive tumors.
    • Sentinel lymph node mapping shows promise for gynecologic cancer management.

    Conclusions:

    • Imaging technologies are becoming increasingly valuable for cervical cancer assessment.
    • Advances in imaging, contrast agents, and combined techniques improve detection of metastases.
    • Enhanced staging through advanced imaging can lead to improved treatment selection and survival rates.